TRANSPLANT HOUSE (EIN 260585694) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2007

Legal Domicile

Principal Officer

RICHARD D HASZ

Phone

2155578090

Tax Period

2023-01-01 to 2023-12-31

TRANSPLANT HOUSE, founded in 2007, is a community nonprofit in the Health Care sector that reported $2.5M in total revenue in fiscal year 2023. Revenue decreased 15% compared to the prior year. Expenses of $2.8M exceeded revenue, resulting in a 10% operating deficit.

Mission

TO PROVIDE TEMPORARY, AFFORDABLE LODGING TO THOSE WHO TRAVEL TO PHILADELPHIA, PA FOR TRANSPLANT CARE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $2,009,879

Program Service Revenue $355,221

Investment Income $174,802

Other Revenue $-10,027

TOTAL REVENUE $2,529,875

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,227,134

Fundraising Expenses $371,814

Program Expenses $2,232,709

Other Expenses $1,561,454

TOTAL EXPENSES $2,788,588

Year-over-Year Comparison

	2023	2022	Change
Revenue	$2,529,875	$2,973,791	-0.1%
Expenses	$2,788,588	$2,685,908	+0.0%
Net Income	$-258,713	$287,883	-1.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

2700

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,658,303

Total Directors

$1,129,726

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RICHARD D HASZ	PRESIDENT & CEO	2.00	Officer Director	$0	$152,621	$946,726
CLYDE F BARKER MD	DIRECTOR	0.30	Director	$0	$0	$0
MICHAEL MORITZ MD	MEDICAL DIRECTOR	0.30	Director	$0	$0	$183,000
MARTHA ANDERSON	DIRECTOR	0.30	Director	$0	$0	$0
JAN L WEINSTOCK ESQ	CHIEF ADMIN OFFICER & GEN	4.50	Officer	$0	$71,156	$711,577
TALIA C GIORDANO	DIRECTOR CAREGIVER LIFELIN	40.00	Highest	$108,335	$26,905	$135,240
SARAH COHEN	DIRECTOR/DEVELOPMENT	40.00	Highest	$112,978	$22,834	$135,812
HOWARD NATHAN	FORMER OFFICER/FOUNDATION EX DIR	0.00		$0	$60,491	$387,665

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$2,529,875	$2,788,588	$20,730,504	$-258,713
2022	$2,973,791	$2,685,908	$19,534,996	$287,883
2021	$3,164,434	$2,444,435	$20,620,170	$719,999
2020	$2,408,736	$2,242,685	$21,151,618	$166,051
2019	$3,156,405	$2,288,139	$19,303,580	$868,266
2018	$3,745,514	$2,164,071	$17,296,686	$1,581,443

TRANSPLANT HOUSE